http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0009476-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fd6bf1be475a960836c26c18f926078 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-49 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-49 |
filingDate | 1999-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e23fd926f0d35e0b9a5f2847f9e52258 |
publicationDate | 2000-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-0009476-B1 |
titleOfInvention | Fatty acid derivatives |
abstract | The invention relates to a novel acylate which is the reaction product of (a) a substance which is selected from the group consisting of naturally occurring alpha-aminocarboxylic acids, neurotransmitters other than such acids, and central or peripheral nervous system pharmacologically active compounds, and containing a functional group including an acylatable hydrogen atom, or a reactive derivative thereof; and (b) an essential fatty acid or a reactive derivative thereof; and including the pharmaceutically acceptable salts of such acylates possessing a basic and/or acidic function; and to their functional derivatives. The acylates and their functional derivatives may be used for treatment of a disease or condition related to a neurotransmitter defector deficiency, or to another central or peripheral nervous system defect or deficiency, and in particular Parkinson's disease. |
priorityDate | 1998-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 128.